HomeCompareCDMOP vs SPHD

CDMOP vs SPHD: Dividend Comparison 2026

CDMOP yields 74.49% · SPHD yields 4.00%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CDMOP wins by $7.4K in total portfolio value
10 years
CDMOP
CDMOP
● Live price
74.49%
Share price
$25.06
Annual div
$18.67
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$35.4K
Annual income
$13.10
Full CDMOP calculator →
SPHD
SPHD
● Live price
4.00%
Share price
$50.00
Annual div
$2.00
5Y div CAGR
5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$28.0K
Annual income
$899.19
Full SPHD calculator →

Portfolio growth — CDMOP vs SPHD

📍 CDMOP pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCDMOPSPHD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CDMOP + SPHD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CDMOP pays
SPHD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CDMOP
Annual income on $10K today (after 15% tax)
$6,331.79/yr
After 10yr DRIP, annual income (after tax)
$11.14/yr
SPHD
Annual income on $10K today (after 15% tax)
$340.00/yr
After 10yr DRIP, annual income (after tax)
$764.31/yr
At 15% tax rate, SPHD beats the other by $753.18/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CDMOP + SPHD for your $10,000?

CDMOP: 50%SPHD: 50%
100% SPHD50/50100% CDMOP
Portfolio after 10yr
$31.7K
Annual income
$456.15/yr
Blended yield
1.44%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CDMOP right now

CDMOP
Analyst Ratings
7
Buy
Consensus: Buy
SPHD
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CDMOP buys
0
SPHD buys
0
No recent congressional trades found for CDMOP or SPHD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCDMOPSPHD
Forward yield74.49%4.00%
Annual dividend / share$18.67$2.00
Payout ratio50%50%
1-year div growth0%5%
5-year div CAGR-50%5%
Portfolio after 10y$35.4K$28.0K
Annual income after 10y$13.10$899.19
Total dividends collected$9.3K$6.4K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: CDMOP vs SPHD ($10,000, DRIP)

YearCDMOP PortfolioCDMOP Income/yrSPHD PortfolioSPHD Income/yrGap
1← crossover$14,425$3,724.58$11,120$420.00+$3.3KCDMOP
2$17,945$2,510.54$12,357$458.31+$5.6KCDMOP
3$20,660$1,459.45$13,721$499.76+$6.9KCDMOP
4$22,892$785.19$15,227$544.58+$7.7KCDMOP
5$24,901$406.54$16,885$593.02+$8.0KCDMOP
6$26,851$206.64$18,713$645.34+$8.1KCDMOP
7$28,834$104.12$20,724$701.81+$8.1KCDMOP
8$30,905$52.25$22,938$762.73+$8.0KCDMOP
9$33,094$26.17$25,372$828.41+$7.7KCDMOP
10$35,424$13.10$28,047$899.19+$7.4KCDMOP

CDMOP vs SPHD: Complete Analysis 2026

CDMOPStock

Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. It produces monoclonal antibodies and recombinant proteins; and offers services, including CGMP clinical and commercial drug substance manufacturing, purification, bulk packaging, release and stability testing, and regulatory submission and support. The company also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, testing, and characterization. It serves biotechnology and pharmaceutical companies. Avid Bioservices, Inc. has a process development and manufacturing agreement with Oragenics, Inc. to develop coronavirus vaccine. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was founded in 1981 and is headquartered in Tustin, California.

Full CDMOP Calculator →

SPHDETF

SPHD is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in SPHD shares.

Full SPHD Calculator →
📬

Get this CDMOP vs SPHD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CDMOP vs SCHDCDMOP vs JEPICDMOP vs OCDMOP vs KOCDMOP vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.